Kokia E, Hurwitz A, Ben-Shlomo I, Adashi E Y, Yanagishita M
Department of Obstetrics/Gynecology, University of Maryland School of Medicine, Baltimore 21201-1559.
Endocrinology. 1993 Nov;133(5):2391-4. doi: 10.1210/endo.133.5.8404691.
An increasing body of information supports the possibility that intraovarian interleukin (IL)-1 may play an intermediary role in gonadotropin-triggered ovulation. To further evaluate this hypothesis, we have examined the effect of IL-1 beta on ovarian proteoglycan/glycosaminoglycan economy, an established corollary of the preovulatory cascade. Rat ovarian cells were metabolically labeled with [35S]sulfate and [3H]glucosamine for 48h in the absence or presence of IL-1 beta, with or without an IL-1 receptor antagonist (IL-1ra). At the conclusion of this treatment period, total 35S and 3H incorporation into cell-associated and extracellular proteoglycan/glycosaminoglycan species was determined. Treatment of whole ovarian dispersates with IL-1 beta (10 ng/ml) produced substantial increments in the accumulation of extracellular macromolecular material [11.5-, 2.9- and 2.6-fold for hyaluronic acid (HA), heparan sulfate (HS) and dermatan sulfate (DS) proteoglycans, respectively]. In contrast, only modest increments (< or = 1.7-fold) were noted for IL-1 beta-treated granulosa cells (GC), theca-interstitial cells (TC), or 4:1 co-cultures (GC/TC) thereof. Treatment of whole ovarian dispersates with IL-1 beta also resulted in significant (P < 0.001) increments in the cell-associated accumulation of both HA (6.0-fold increase) and DS proteoglycans (3.4-fold increase). However, the cell-associated accumulation of HS proteoglycan was not significantly affected by IL-1 beta regardless of the cellular preparation under study. The concurrent provision of IL-1ra (5 micrograms/ml) all but neutralized the IL-1 beta effect on HA biosynthesis thereby suggesting mediation by specific ovarian IL-1 receptor(s). Taken together, these observations suggest that treatment of ovarian cells with IL-1 beta results in an overall increase in macromolecular biosynthesis as well as in redistribution favoring extracellular HA and DS (but not HS) proteoglycans. Moreover, since whole ovarian dispersates proved more responsive to IL-1 than isolated cellular components thereof, the present observations suggest an obligatory requirement for heterologous cell-cell interaction without which optimal HA or proteoglycan biosynthesis may not be realized. These observations along with the demonstration of IL-1-mediated amplification of gonadotropin-triggered ovulation provide strong indirect support for the view that IL-1 may be the centerpiece of an intraovarian regulatory loop concerned with the promotion of key periovulatory events.
越来越多的信息支持卵巢内白细胞介素(IL)-1可能在促性腺激素触发排卵过程中起中介作用这一可能性。为了进一步评估这一假说,我们研究了IL-1β对卵巢蛋白聚糖/糖胺聚糖代谢的影响,这是排卵前级联反应的一个既定结果。在有无IL-1β、有无IL-1受体拮抗剂(IL-1ra)的情况下,用[35S]硫酸盐和[3H]葡萄糖胺对大鼠卵巢细胞进行48小时的代谢标记。在这个处理期结束时,测定细胞相关和细胞外蛋白聚糖/糖胺聚糖种类中35S和3H的总掺入量。用IL-1β(10 ng/ml)处理整个卵巢分散物,可使细胞外大分子物质的积累显著增加[透明质酸(HA)、硫酸乙酰肝素(HS)和硫酸皮肤素(DS)蛋白聚糖分别增加11.5倍、2.9倍和2.6倍]。相比之下,IL-1β处理的颗粒细胞(GC)、卵泡膜间质细胞(TC)或它们的4:1共培养物(GC/TC)中仅观察到适度增加(≤1.7倍)。用IL-1β处理整个卵巢分散物也导致细胞相关的HA(增加6.0倍)和DS蛋白聚糖(增加3.4倍)积累显著增加(P<0.001)。然而,无论所研究的细胞制剂如何,HS蛋白聚糖的细胞相关积累均未受到IL-1β的显著影响。同时提供IL-1ra(5μg/ml)几乎完全中和了IL-1β对HA生物合成的影响,从而提示由特定的卵巢IL-1受体介导。综上所述,这些观察结果表明,用IL-1β处理卵巢细胞会导致大分子生物合成总体增加,以及有利于细胞外HA和DS(而非HS)蛋白聚糖的重新分布。此外,由于整个卵巢分散物对IL-1的反应比其分离的细胞成分更敏感,目前的观察结果表明需要异源细胞间相互作用,否则可能无法实现最佳的HA或蛋白聚糖生物合成。这些观察结果以及IL-1介导的促性腺激素触发排卵的放大作用的证明,为IL-1可能是与促进关键排卵前事件有关的卵巢内调节环路的核心这一观点提供了有力的间接支持。